Related Experiment Videos
[Ion pair-HPLC of a pharmaceutical multicomponent system].
Die Pharmazie
|November 1, 1988
Summary
This study optimized ion-pair High-Performance Liquid Chromatography (HPLC) for analyzing bronchodilator drugs. The method effectively separates non-ionic and ionic compounds in complex pharmaceutical formulations.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Analysis
Context:
- Aminophyllin compositum tablets contain a mixture of non-ionic (methyl- and propylhydroxybenzoate) and ionic (theophylline, phenobarbital, atropine methobromide, demelverine hydrochloride) analytes.
- These analytes are therapeutically used as effective bronchodilators.
Purpose:
- To investigate and optimize an ion-pair High-Performance Liquid Chromatography (HPLC) technique for the simultaneous analysis of a multicomponent system of non-ionic and ionic analytes.
- To evaluate the effectiveness of different ion-interaction reagents (IIR), including alkylsulfonates and sodium cyclamate, for separating these compounds on reversed-phase columns.
- To study the influence of various factors on analyte retention and explore the use of 'mixed' IIR for enhanced separation.
Summary:
- An ion-pair HPLC method was developed and applied to a complex mixture of non-ionic and ionic compounds found in bronchodilator formulations.
- The study systematically investigated the use of alkylsulfonates and sodium cyclamate as ion-interaction reagents (IIR), detailing their impact on chromatographic retention.
- The research explored the potential of employing 'mixed' IIR strategies to achieve improved separation of the analytes, demonstrating a practical approach to pharmaceutical analysis.
Impact:
- Provides an optimized analytical method for the quality control of multicomponent bronchodilator medications.
- Offers insights into the selection and application of ion-interaction reagents for complex pharmaceutical separations using HPLC.
- Contributes to the advancement of analytical techniques for the precise determination of both ionic and non-ionic active pharmaceutical ingredients in drug products.